Please login to the form below

Not currently logged in
Email:
Password:

Ariad appoints new CEO

Paris Panayiotopoulos joins the US biotech from EMD Serono

Ariad Paris PanayiotopoulosParis Panayiotopoulos has moved from EMD Serono to join Ariad as its new president and CEO.

Panayiotopoulos succeeds Ariad's founder, chairman and CEO Harvey Berger who is retiring from the Cambridge, US-based biotech company he set up 23 years ago.

Berger will continue at Ariad for a time, serving as a special advisor to its board and new CEO Panayiotopoulos as part of the transition process.

Wayne Wilson, lead director for Ariad, said: “Paris is a dynamic leader with a proven ability to set vision, define strategy, build culture and align teams to successfully execute against objectives.

“He has the necessary skills to bring a renewed focus to company execution as we work together to explore all paths in maximising value for shareholders.”

Prior to his time at EMD Serono, where he was its president, and its parent company Merck KGaA Panayiotopoulos was at Lilly.

Panayiotopoulos said: “I am very pleased to be joining ARIAD at this exciting time. Together with our passionate and highly capable employees, I fully expect that we will maximise the company's commercial potential and further strengthen its pipeline.”

5th January 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Sustainability
Environment: where does the pharmaceutical industry stand?
...
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...